{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:04Z","timestamp":1786982704057,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s13760-017-0839-y","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T08:05:48Z","timestamp":1506067548000},"page":"545-548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An investigation on the effects of carbamazepine and sodium valproate on neuromuscular transmission"],"prefix":"10.1007","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-7698","authenticated-orcid":false,"given":"Halil","family":"Ay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Ethemo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"issue":"10","key":"839_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 14(10):1023\u20131036","journal-title":"Lancet Neurol."},{"key":"839_CR2","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1152\/ajpcell.1997.273.6.C1835","volume":"273","author":"A Losavio","year":"1997","unstructured":"Losavio A, Muchnik S (1997) Spontaneous acetylcholine release in mammalian neuromuscular junctions. Am J Physiol 273:1835\u20131841","journal-title":"Am J Physiol"},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0896-6273(89)90029-9","volume":"3","author":"BE Flucher","year":"1989","unstructured":"Flucher BE, Daniels MP (1989) Distribution of Na+\u00a0channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kd protein. Neuron. 3:163\u2013175","journal-title":"Neuron."},{"key":"839_CR4","unstructured":"Bora \u0130 (2008) Epilepsi Nobel t\u0131p kitap evi, birinci bask\u0131 600"},{"issue":"10","key":"839_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca E (2002) Pharmacological and therapeutic properties of valproate: a summary after 35\u00a0years of clinical experience. CNS Drugs. 16(10):695\u2013714","journal-title":"CNS Drugs."},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuropharm.2007.05.030","volume":"53","author":"T Broicher","year":"2007","unstructured":"Broicher T, Seidenbecher T, Meuth P, Munsch T, Meuth SG, Kanyshkova T, Pape HC, Budde T (2007) T-current related effects of antiepileptic drugs and a Ca2+\u00a0channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy. Neuropharmacology 53:431\u2013446","journal-title":"Neuropharmacology"},{"key":"839_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1528-1157.1986.tb03525.x","volume":"27","author":"AM VanDongen","year":"1986","unstructured":"VanDongen AM, VanErp MG, Voskuyl RA (1986) Valproate reduces excitability by blockage of sodium and potassium conductance. Epilepsia. 27:177\u2013182","journal-title":"Epilepsia."},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1081\/CLT-120002889","volume":"40","author":"HA Spiller","year":"2002","unstructured":"Spiller HA, Carlisle RD (2002) Status epilepticus after massive carbamazepine overdose. J Toxicol Clin Toxicol 40:81\u201390","journal-title":"J Toxicol Clin Toxicol"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1046\/j.1472-8206.2001.00055.x","volume":"15","author":"E Perucca","year":"2001","unstructured":"Perucca E (2001) Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundam Clin Pharmacol 15:405\u2013417","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"839_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/0972-2327.107690","volume":"16","author":"Ajith Cherian","year":"2013","unstructured":"Cherian Ajith, Baheti Neeraj N, Iype Thomas (2013) Electrophysiological study in neuromuscular junction disorders. Ann Indian Acad Neurol 16(1):34\u201341","journal-title":"Ann Indian Acad Neurol"},{"issue":"3","key":"839_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/mus.24750","volume":"53","author":"E Stalberg","year":"2016","unstructured":"Stalberg E, Sanders DB, Ali S, Cooray G, Leonardis L, L\u00f6seth S, Machado F, Maldonado A, Martinez-Aparicio C, Sandberg A, Smith B, Widenfalk J, Aris Kouyoumdjian J (2016) Reference values for jitter recorded by concentric needle electrodes in healthy controls: a multicenter study. Muscle Nerve 53(3):351\u2013362","journal-title":"Muscle Nerve"},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/1097-4598(200008)23:8<1204::AID-MUS7>3.0.CO;2-H","volume":"23","author":"N Boneva","year":"2000","unstructured":"Boneva N, Brenner T, Argov Z (2000) Gabapentin may be hazardous in myasthenia gravis. Muscle Nerve 23:1204\u20131208","journal-title":"Muscle Nerve"},{"key":"839_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1528-1157.1981.tb06157.x","volume":"22","author":"EL So","year":"1981","unstructured":"So EL, Penry JK (1981) Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: a review. Epilepsia 22:467\u2013473","journal-title":"Epilepsia"},{"key":"839_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1055\/s-2003-43257","volume":"34","author":"MA Kurian","year":"2003","unstructured":"Kurian MA, King MD (2003) Antibody positive myasthenia gravis following treatment with carbamazepine\u2014a chance association? Neuropediatrics 34:276\u2013277","journal-title":"Neuropediatrics"},{"key":"839_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1055\/s-2004-817956","volume":"35","author":"M Rasmussen","year":"2004","unstructured":"Rasmussen M (2004) Carbamazepine and myasthenia gravis. Neuropediatrics 35:259","journal-title":"Neuropediatrics"},{"key":"839_CR16","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1152\/ajpcell.1997.273.6.C1835","volume":"273","author":"A Losavio","year":"1997","unstructured":"Losavio A, Muchnik S (1997) Spontaneous acetylcholine release in mammalian neuromuscular junctions. Am J Physiol 273:1835\u20131841","journal-title":"Am J Physiol"},{"issue":"1","key":"839_CR17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)32260-3","volume":"215","author":"MT Alderdice","year":"1980","unstructured":"Alderdice MT, Trommer BA (1980) Differential\u00a0effects\u00a0of the anticonvulsants phenobarbital, ethosuximide and carbamazepine\u00a0on neuromuscular transmission. J Pharmacol Exp Ther 215(1):92\u201396","journal-title":"J Pharmacol Exp Ther"},{"key":"839_CR18","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.clinph.2007.06.002","volume":"118","author":"Y Ozkul","year":"2007","unstructured":"Ozkul Y (2007) Influence of calcium channel blocker drugs in neuromuscular transmission. Clin Neurophysiol 118:2005\u20132008","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"839_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1468-2982.2003.00409.x","volume":"23","author":"A Ambrosini","year":"2003","unstructured":"Ambrosini A, Pierelli F, Schoenen J (2003) Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs. Cephalalgia 23(2):75\u201378","journal-title":"Cephalalgia"},{"key":"839_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/(SICI)1097-4598(199808)21:8<1081::AID-MUS16>3.0.CO;2-X","volume":"21","author":"L Murga","year":"1998","unstructured":"Murga L, Sanchez F, Menendez C, Castilla JM (1998) Diagnostic yield of stimulation and voluntary single fiber electromyography in myasthenia gravis. Muscle Nerve 21:1081\u20131083","journal-title":"Muscle Nerve"},{"key":"839_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/mus.21151","volume":"39","author":"ME Farrugia","year":"2009","unstructured":"Farrugia ME, Weir AI, Cleary M, Cooper S, Metcalfe R, Mallik A (2009) Concentric and single fiber needle electrodes yield comparable jitter results in myasthenia gravis. Muscle Nerve 39:579\u2013585","journal-title":"Muscle Nerve"},{"key":"839_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<715::AID-MUS8>3.0.CO;2-V","volume":"23","author":"M Erta\u015f","year":"2000","unstructured":"Erta\u015f M, Baslo MB, Yildiz N, Yazici J, Oge AE (2000) Concentric needle electrode for neuromuscular jitter analysis. Muscle Nerve 23:715\u2013771","journal-title":"Muscle Nerve"},{"key":"839_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/mus.880010304","volume":"1","author":"BM Patten","year":"1978","unstructured":"Patten BM (1978) Myasthenia gravis: review of diagnosis and management. Muscle Nerve 1:190\u2013205","journal-title":"Muscle Nerve"},{"key":"839_CR24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ana.410130506","volume":"13","author":"M Rodriguez","year":"1983","unstructured":"Rodriguez M, Gomez MR, Howard FM Jr, Taylor WF (1983) Myasthenia gravis in children. Ann Neurol 13:504\u2013510","journal-title":"Ann Neurol"},{"key":"839_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0370-4475(82)80055-5","volume":"12","author":"A Tartara","year":"1982","unstructured":"Tartara A, Mola M, Manni R et al (1982) EEG findings in 118 cases of myasthenia gravis. Rev Electroencephalogr Neurophysiol Clin. 12:275\u2013279","journal-title":"Rev Electroencephalogr Neurophysiol Clin."}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-017-0839-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-017-0839-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-017-0839-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T17:29:08Z","timestamp":1750872548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-017-0839-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s13760-017-0839-y","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,22]]},"assertion":[{"value":"8 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author Halil Ay declares that he has no conflict of interest. Author \u00d6zlem Ethemo\u011flu declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent forms were approved for each subject separately for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"There was no funding for this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}